Effect of hydralazine on duration of soft tissue local anesthesia following dental treatment: a randomized clinical trial.
Prolonged numbness following routine dental treatments can cause difficulties in speaking and swallowing and may result in inadvertent biting of soft tissues. Local injection of vasodilator agents may represent a solution to this problem. The aim of this study was to evaluate the effect of submucosal injection of hydralazine hydrochloride (HCl) on the duration of oral soft tissue anesthesia after routine dental treatment. This randomized, single-blinded, controlled clinical trial included 50 patients who received inferior alveolar nerve block (2% lidocaine with 1:100,000 epinephrine) for simple restorative treatment. Upon completion of the dental treatment, patients randomly received a hydralazine HCl or sham injection in the same site as the local anesthetic injection. The reversal time to normal sensation of soft tissues (lips, tongue, and perioral skin) was evaluated and reported every 5 minutes by the patients, who followed an assessment protocol that they were taught in advance of treatment. Median recovery times in the hydralazine group and the sham group were 81.4 (SD, 3.6) and 221.8 (SD, 6.3) minutes, respectively. Based on Kaplan-Meier survival analysis, the duration of soft tissue anesthesia in the 2 groups was significantly different (P < 0.0001). By 1 hour after the reversal injection, 76% of subjects receiving hydralazine HCl had returned to normal intraoral and perioral sensation, but none of the subjects in the sham group reported normal sensation. Based on these results, submucosal injection of hydralazine HCl can be considered a safe and effective method to reduce the duration of local anesthetic-induced soft tissue numbness and the related functional problems.
Omid
O
Fakheran Esfahani
Mohammad Fazel
MF
Pouraboutaleb
Behnam
B
Khorami
D000328:Adult; D000766:Anesthesia, Dental / Q000009:adverse effects / Q000379:methods*; D000772:Anesthesia, Local / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D007267:Injections; D008046:Lip / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009055:Mouth / Q000187:drug effects; D016037:Single-Blind Method; D013997:Time Factors; D014059:Tongue / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*; D055815:Young Adult
D014665:Vasodilator Agents; D006830:Hydralazine
epinephrine; hydralazine hydrochloride; lidocaine; local anesthesia